At the end of this month, 84,000 people in Pax Lovid and 100,000 people in La Gabrio are scheduled to be introduced.
In April, 276,000 additional people were introduced… Exchanging treatment with foreign countries like vaccines
(Seoul = Yonhap News) Reporter Hyo-rim Ryu = ‘Paxrovid’ supplied to a pharmacy in charge of oral treatment for COVID-19 in downtown Seoul. 2022.2.21 [email protected]
(Seoul = Yonhap News) Reporter Seo-Young Kim = The government announced that it would introduce a total of 460,000 doses by the end of next month by advancing the introduction of oral (edible) treatment for COVID-19.
The Central Disaster and Safety Countermeasures Headquarters said that while a total of 1,400,000 oral medications that have been secured so far are being sequentially introduced into Korea, they are pushing for a plan to introduce a total of 460,000 doses early, including some that have been delivered by the end of April. work said
There are two oral treatments currently being prescribed in Korea: Pfizer’s ‘Paxrovid’ and Merck & Company’s ‘Laguebrio’ (ingredient name: Molnupiravir).
As of the 24th, a total of 163,000 people were introduced to Pax Lovid. From January 24 to the previous day, it was used for 113,783 people, including home healers, living treatment centers, and patients at infectious disease hospitals, and the remaining amount is 48,947 people.
In addition, the amount of Pax Lovid that arrived on this day (44,000 people) and the amount that will be delivered within this month (40,000 people) is added for 84,000 people, and for 20,000 Laguebrio, which was first delivered on the 23rd and used from the 26th. A total of 184,000 people will arrive by the end of this month, including 100,000 people, including 80,000 people who will arrive on the 27th.
In addition, since 276,000 additional doses are scheduled to be introduced in April, the government explains that 460,000 doses of treatment will be delivered for about a month from the end of March to the end of April.
However, the detailed quantity of drugs to be introduced next month by pharmaceutical company will be disclosed at a later date.
(Cheongju = Yonhap News) Reporter Cheon Kyung-hwan = Lagevrio, an oral (edible) treatment for COVID-19, arrived at the Ochang logistics center of Yuhan Corporation in North Chungcheong Province on the 24th. 2022.3.24 [email protected]
Lee Ki-il, 1st Supervisor of the SAR, said at a briefing on the same day, “There is an additional amount to be introduced in April, so we are discussing positively now.” ) We are also reviewing overseas (prescription) cases for the treatment ‘Ibushield’,” he explained.
If necessary, the authorities said they will also consider exchanging food treatments with foreign governments by borrowing the ‘swap’ method used when the COVID-19 vaccine was introduced.
Although the number of patients has recently decreased, the government is accelerating the introduction of treatments, expecting that the number of severe cases will reach a peak from the end of this month with a time lag from the peak of confirmed cases.
While voices complaining about the shortage of medicines in the medical field continue, the government actively countered that sufficient quantities were being introduced.
Prime Minister Bu-gyeom Kim said at a meeting of the Corona 19 major headquarters presided over at the Sejong Government Complex on the same day, “As we continue to expand the number of prescriptions and institutions, more than 7,000 people are taking the drug a day recently, and the stock is also rapidly decreasing.” I am making it clear that it is not at all true that I cannot receive prescriptions for the drug.”
Prime Minister Kim said, “We are taking preemptive measures to ensure that there is no shortage of medicines eaten at front-line medical sites.” We are in the final stage,” he said.
(Seoul = Yonhap News) Reporter Ryu Hyo-rim = The Central Disaster and Safety Countermeasures Headquarters announced on February 16 that it will expand the number of pharmacies for dispensing, dispensing, and delivering medicines, such as antipyretics, to all neighborhood pharmacies for COVID-19 at-home healers. However, ‘Paxrovid’, an oral (edible) treatment for COVID-19, can only be obtained from 472 pharmacies designated by each city, county, and gu as it is now. The photo shows a pharmacy in downtown Seoul on that day. [email protected]
Meanwhile, from the 26th, the government began to prepare a system to prevent misuse of the new treatment, Lagevrio, which is being prescribed in earnest.
Lagevrio was approved for emergency use on the 23rd and is prescribed to patients in earnest from the 26th. administered to the subject. However, pregnant women and children and adolescents under the age of 18 are excluded from the treatment.
The authorities have completed the registration of the Drug Safe Use Service (DUR) system to prevent incorrect prescriptions for pregnant women, children and adolescents, and added drug information to the patient management information system.
In addition, a ‘treatment guide’ related to the prescription of Lagevrio has been distributed to medical institutions, and pharmacies are planning to provide detailed medication guides to patients.
If side effects occur after using the drug, you can report it to the Korea Drug Safety Management Agency (drugsafe.or.kr. or ☎ 1644-6223) or receive related counseling.
Report on Kakao Talk okjebo
<저작권자(c) 연합뉴스,
Unauthorized reproduction-redistribution prohibited>
2022/03/25 14:53 Send